Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

State Medicaid Program Issues: Preferred Drug Lists, 2003

This issue brief identifies issues, requirements and considerations relating to preferred drug lists (PDLs). Developed for state audiences, the brief addresses policy, operational and procedural concerns; federal provisions for patient protection; specific case studies; provisions of the Florida Medicaid patient suit settlement agreement; evaluation methodologies; and principles to consider.

Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Medicaid Expansion & Historical Data

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
YouTube Videos

Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

There is a bit of a "black box" around the formulary decision-making process. As a result, decisions about treatment access are often unpredictable...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

NPC Conference to Address Questions on Ability to Share Health Research Findings Health

(Washington, DC, February 6, 2012)--To examine key issues around asymmetries, or inequalities, in communicating health information coming from the...
Press Release

National Pharmaceutical Council Selects Five Research Projects for Funding

Washington, DC (January 30, 2012) – The National Pharmaceutical Council (NPC) today announced that it has selected five projects related to...
Press Release

National Pharmaceutical Council Expands Policy and Research Staff

WASHINGTON, DC (January 4, 2012) -- The National Pharmaceutical Council (NPC) announced the hiring of Daryl Pritchard, PhD, as the Director of...
Commentary and Testimony Page

Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making

The number of voices in the comparative effectiveness research (CER) conversation is continuing to grow, but not all stakeholders have the same...
Commentary and Testimony Page

CER Done Right: Why It Matters

The health care reform law is aimed at reshaping the health care landscape through the creation of many new regulations and regulatory...
Commentary and Testimony Page

What Will 2011 Hold for CER and PCORI?

When future historians consider health care, they may well look back on 2010 as a watershed year in America. The issues and events that occurred last...
Commentary and Testimony Page

NPC Reflects on Changes in 2010

It’s been a year of great change not only for the biopharmaceutical industry, but for the National Pharmaceutical Council as well. With these changes...
YouTube Videos

Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

There is a bit of a "black box" around the formulary decision-making process. As a result, decisions about treatment access are often unpredictable...
YouTube Videos

PCORI Outlines Efforts to Engage Patients

Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...
YouTube Videos

How Do Payers Consider Individual Treatment Effects?

Dr. Robert Epstein, former chief medical officer and senior vice president of medical affairs at Medco Health, explains that heterogeneity, or...
YouTube Videos

AEI's Gottlieb on Ability to Communicate CER Findings

American Enterprise Institute's Dr. Scott Gottlieb discusses legal and regulatory challenges facing various health care stakeholders in their...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Medicaid Expansion & Historical Data

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

NPC Webinar: Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?

Why are some treatments covered under a health care plan, while other treatments are not? How do payers evaluate the information needed to make...
Blog Post

A Step Toward Clear, Consistent, Transparent Formulary Decisions

The process that health insurers use to determine health coverage is not always clear, making it hard for patients, providers and biopharmaceutical...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

Transparency in Evidence Evaluation and Formulary Decision-Making

Although the type of evidence required to make healt

  •  
  • 1 of 42
  • >

Commentary & Testimony